<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000822'>Hypertension</z:hpo> can lead to <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> and eventually to <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>It has been suggested that the latter could be the result of <z:mp ids='MP_0003674'>oxidative stress</z:mp> and an <z:mp ids='MP_0001845'>inflammatory response</z:mp> evoked by <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Because an unavoidable consequence of <z:mp ids='MP_0001914'>hemorrhage</z:mp> is lysis of red blood cells, we first tested the hypothesis on carotid arteries that the proinflammatory cytokine <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha contributes to vascular <z:mp ids='MP_0003674'>oxidative stress</z:mp> evoked by <z:mp ids='MP_0010163'>hemolysis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>We observed that <z:mp ids='MP_0010163'>hemolysis</z:mp> induces a significant increase in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha both in blood and in vascular tissues, where it provokes Rac-1/<z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase-mediated <z:mp ids='MP_0003674'>oxidative stress</z:mp> and vasoconstriction </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, we extended our observations to cerebral vessels, demonstrating that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha triggered this mechanism on the basilar artery </plain></SENT>
<SENT sid="5" pm="."><plain>Finally, in an in vivo model of <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> obtained by the administration of hemolyzed blood in the cisterna magna, we demonstrated, by high-resolution ultrasound analysis, that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha inhibition prevented and resolved <z:hpo ids='HP_0011009'>acute</z:hpo> cerebral vasoconstriction </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha inhibition rescued the <z:mp ids='MP_0010163'>hemolysis</z:mp>-induced brain injury, evaluated with the method of 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> and by the histological analysis of pyknotic nuclei </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, our results demonstrate that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha plays a crucial role in the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:mp ids='MP_0010163'>hemolysis</z:mp>-induced vascular injury and can be used as a novel target of the therapeutic strategy against <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
</text></document>